Maria Tsagiopoulou’s Post

Today we are working at conference EHA-KCS Hematology Tutorial on Recent Advances in Lymphoid and Myeloid Malignancies

Join Kx Advisors in Madrid for EHA 2024, hosted by the European Hematology Association (EHA)! Connect with Nikil D. Kumar and Eleanor (Tyler) Maughan, PhD to learn more about how Kx Advisors can help you navigate the increasingly complex world of #hematology!   #EHA2024 #HematologyResearch 

I have prepared a summary of an interesting topic I recently learned which is Hemophagocytic lymphohistiocytosis (HLH). It is one of the cases that I witnessed in the hematology laboratory🤩🔬.

Preparing the last details of the podcast interviews to record at the #EHA2024 European Hematology Association congress.

Last week I presented the first results of the phase 2 ICON study at the European Hematology Association (EHA) conference in Madrid. In the ICON study, relapsed/refractory multiple myeloma patients were treated with iberdomide, low-dose cyclophosphamide and dexamethasone. Iberdomide is a novel cereblon E3 ligase modulator (CELMoD™) with improved direct anti-myeloma activity and immune-stimulatory effects. This treatment regimen resulted in a ORR of 82% and a median PFS of 17.8 months in patients with 2-4 prior lines of therapy. This fully oral, well tolerated, and active combination warrants further evaluation in RRMM. The full abstract is available online: https://lnkd.in/eUqb4Vaq What an interesting conference the #EHA2024 has been! Thanks to all co-authors and my supervisors Niels Van De Donk, Sonja Zweegman and Tuna Mutis.

NEW #Thalassemia Sessions from #ASH23🩸 💬 In this session, leading experts Maria Domenica Cappellini & Kevin Kuo discuss exciting updates in #thalassemia presented at the 2023 ASH Annual Meeting and Exposition The experts cover several topics, including the promise of novel #genetherapies, ongoing #clinicaltrials in the field, and the value of #precisionmedicine 🔬 Take a look 👉 https://lnkd.in/e2-JsM7Y #HemOnc #MPNsm American Society of Hematology

👉 Discover the Latest Clinical Case: A 53-year-old patient diagnosed with 𝐇𝐚𝐢𝐫𝐲 𝐂𝐞𝐥𝐥 𝐋𝐞𝐮𝐤𝐞𝐦𝐢𝐚 (HCL). See how our Yumizen hematology analyzer helped identify key markers and guide the right approach. 🔹Read on website: https://lnkd.in/eJK52mz9 #HairyCellLeukemia #Leukemia #ClinialLab #MedicalLab #Hematology

Also available in Europe

Hematology🩸🔬 In hematology, reticulocytes are immature RBCs.In the process of maturation reticulocyte spend 2 days in bone marrow and one day in peripheral blood. As a result, 1 % of red cells are immature ! Erythropoietin has important role in producing red cells.

📰Published in Seminars in Hematology Review summarizes current evidence of novel antigens & their clinical potential. Together with current CAR T-cell therapy & T-cell engagers, these approaches might lead to the next frontier   READ➡️https://lnkd.in/eMBz4c-D  #MultipleMyeloma